secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOOKIPA Pharma Inc. (HOOK)
CIK:        0001760542
Form:       8-K
Filed at:   2023-12-21T23:59:59+00:00
Accession:  0001104659-23-127949
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Gilead invests $21.25M in HOOKIPA for 15M shares at $1.4167 each
----------------------------------------------------------------

- Gilead purchased 15M shares for ~$21.25M at $1.4167/share; now holds 19.4% of HOOK outstanding stock.
- HOOKIPA may sell up to $8.75M additional shares to Gilead in future equity raises under same agreement.
- Funds to advance HIV therapeutic vaccine HB-500 through Phase 1; trial expected to start H1 2024.
- Agreement replaces 2022 stock purchase agreement; total committed $30M now largely funded.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923127949/0001104659-23-127949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760542/000110465923127949/tm2333370d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-127949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer